DiaSys Corporation Announces First Quarter Financial Information
November 10 2005 - 3:25PM
Business Wire
DiaSys Corporation (AMEX:DYX) a global healthcare products company,
has announced a net loss of $240,507 $(.01) per share on net sales
of $447,143 for its first quarter ended September 30, 2005. For the
first quarter ending September 30, 2004, the company had a net loss
of $491,999 $(.03) per share on net sales of $564,812. DiaSys
Corporation designs, develops, manufactures and distributes
proprietary medical laboratory equipment, consumables and
infectious disease test-kits to healthcare & veterinary
laboratories worldwide. Headquartered in Waterbury, Connecticut
USA, the Company operates in Europe through its wholly owned
subsidiary based in Wokingham, England and in Pacific Asia through
its strategic business partner located in Guangzhou, China. DiaSys,
Parasep and Urisep are registered trademarks of DiaSys Corporation.
This press release contains forward-looking statements within the
meaning of, and made pursuant to, the safe harbor provisions of the
Private Securities Litigation Reform Act of 1995. The forward
looking statements involve known and unknown risks, uncertainties
and other factors which may cause the actual results, performance
or achievements of the Company or events, or timing of events,
relating to the Company to materially differ from those expressed
or implied by such forward looking statements. DiaSys refers
interested parties to its most recent Annual Report on Form 10-KSB
and other SEC filings for a complete description of, and
discussions about, the Company.
Diasys (AMEX:DYX)
Historical Stock Chart
From Apr 2024 to May 2024
Diasys (AMEX:DYX)
Historical Stock Chart
From May 2023 to May 2024